Evidence map›Paper›PMID 39931798›Full record

ArticleAddiction (Abingdon, England)2025

Disentangling the effects of nicotine versus non-nicotine constituents of tobacco smoke on major depressive disorder: A multivariable Mendelian randomisation study.

Chloe Burke, Gemma Taylor, Tom P Freeman, Hannah Sallis, Robyn E Wootton, Marcus R Munafò, Christina Dardani, Jasmine Khouja

Abstract read
In one paragraph

Article in Addiction (Abingdon, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chloe BurkeSchool of Psychological Science, University of Bristol, Bristol, UK.ORCID https://orcid.org/0000-0001-7941-4721
Gemma TaylorDepartment of Psychology, University of Bath, Bath, UK.ORCID https://orcid.org/0000-0003-2185-0162
Tom P FreemanDepartment of Psychology, University of Bath, Bath, UK.ORCID https://orcid.org/0000-0002-5667-507X
Hannah SallisPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.ORCID https://orcid.org/0000-0002-4793-6290
Robyn E WoottonSchool of Psychological Science, University of Bristol, Bristol, UK.ORCID https://orcid.org/0000-0003-3961-3202
Marcus R MunafòSchool of Psychological Science, University of Bristol, Bristol, UK.ORCID https://orcid.org/0000-0002-4049-993X
Christina DardaniMedical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, UK.ORCID https://orcid.org/0000-0002-2019-7897
Jasmine KhoujaSchool of Psychological Science, University of Bristol, Bristol, UK.ORCID https://orcid.org/0000-0002-7944-2981

Funding

Cancer Research UK C18281/A29019Innovative Medicines Initiative 2 Joint Undertaking 777394Medical Research Council (MRC) Integrative Epidemiology Unit at the University of Bristol MC_UU_00032/7Society for the Student of AddictionSouth-Eastern Norway Regional Health Authority 2020024
6 · The paper itself

Abstract

BACKGROUND AND

aimsThere is growing evidence that tobacco smoking causes depression, but it is unclear which constituents of tobacco smoke (e.g. nicotine, carbon monoxide) may be responsible. We used Mendelian randomisation (MR) to measure the independent effect of nicotine on depression, by adjusting the effect of circulating nicotine exposure [via nicotine metabolite ratio (NMR)] for the overall effect of smoking heaviness [via cigarettes per day (CPD)] to account for the non-nicotine constituents of tobacco smoke.

designUnivariable MR and multivariable MR (MVMR) were used to measure the total and independent effects of genetic liability to NMR and CPD on major depressive disorder (MDD). Our primary method was inverse variance weighted (IVW) regression, with other methods as sensitivity analyses. SETTING AND

participantsFor the exposures, we used genome-wide association study (GWAS) summary statistics among European ancestry individuals for CPD (n = 143 210) and NMR (n = 5185). For the outcome, a GWAS of MDD stratified by smoking status was conducted using individual-level data from UK Biobank (n = 35 871-194 881). MEASUREMENTS: Genetic variants associated with NMR (n = 6) and CPD (n = 53).

findingsUnivariable MR-IVW indicated a causal effect of CPD on MDD [odds ratio (OR) = 1.13, 95% confidence interval (CI) = 1.04-1.23, P = 0.003] but no clear evidence for an effect of NMR on MDD (OR = 0.98, 95% CI = 0.97-1.00, P = 0.134). MVMR indicated a causal effect of CPD on MDD when accounting for NMR (IVW: OR = 1.19, 95% CI = 1.03-1.37, P = 0.017; Egger: OR = 1.13, 95% CI = 0.89-1.43, P = 0.300) and weak evidence of a small effect of NMR on MDD when accounting for CPD (IVW: OR = 0.98, 95% CI = 0.96-1.00, P = 0.057; Egger: OR = 0.98, 95% CI = 0.96-1.00, P = 0.038).

conclusionsThe role of nicotine exposure in risk of depression cannot be entirely dismissed. However, the causal effect of tobacco smoking increasing depression risk appears to be largely independent of circulating nicotine exposure, which implies the role of alternative causal pathways.

Indexed as

Major Depressive DisorderNicotineFemaleGenome-Wide Association StudyHumansMaleMendelian Randomization AnalysisMiddle AgedPolymorphism, Single NucleotideUnited KingdomNicotinedepressionMendelian randomisationnicotinesmokingtobaccoUK biobank

Identifiers

PMID39931798
PMCPMC12046462

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.